Lucasq,
Respect your opinions and the opportunity to write whatever you feel. IMO suggest it better not to divert discussion/comments away from business fundamentals such as whether we can launch in Q4 2020. Surely more currently relevant to shareholders suffering from a low share price than biological queries ?
Biologics - The New Asthma Medication, page-14
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 122878 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 30000 | 1 |
View Market Depth
| Last trade - 15.02pm 14/10/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable